112 results
Page 3 of 6
8-K
EX-10.1
zhdsc5ytpcgovhjf2gy
20 Mar 20
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
69gily
6 Jan 20
OncoCyte Announces $7.6 Million Registered Offering
5:29pm
8-K
EX-10.1
qa4k7n r30
27 Dec 19
Entry into a Material Definitive Agreement
5:16pm
8-K
EX-10.1
qlab5f 5xvwj6
14 Nov 19
Entry into a Material Definitive Agreement
6:33am
8-K
EX-10.1
cn70byonrxpy hxq
21 Oct 19
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.2
26kidolbocp5i 47z7ee
21 Oct 19
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.2
wmdfr4 mtqy
3 Oct 19
Oncocyte Closes Initial Investment In Razor Genomics and Acquires Rights to Commercialize Razor Lung Cancer Treatment Stratification Test
12:00am
8-K
EX-10.4
5lcd0d ju
3 Oct 19
Oncocyte Closes Initial Investment In Razor Genomics and Acquires Rights to Commercialize Razor Lung Cancer Treatment Stratification Test
12:00am
8-K
EX-10.1
tbvxupz v98j
3 Oct 19
Oncocyte Closes Initial Investment In Razor Genomics and Acquires Rights to Commercialize Razor Lung Cancer Treatment Stratification Test
12:00am
8-K
EX-10.3
k7fsje mm
3 Oct 19
Oncocyte Closes Initial Investment In Razor Genomics and Acquires Rights to Commercialize Razor Lung Cancer Treatment Stratification Test
12:00am
8-K
EX-10.1
p9f0xse yp
8 Jul 19
Departure of Directors or Certain Officers
4:56pm
8-K
EX-10.1
fqvj7 86o55b7vgpmg
6 Jun 19
Oncocyte Announces Chief Executive Officer Transition
6:35am
8-K
EX-10.2
4howrfxrzfo dyygl9v
1 Aug 18
OncoCyte Announces At Market $3.59 Million Offering of Common Stock and Warrants
4:30pm
8-K
EX-10.1
vptkvybd tlskilg76gq
1 Aug 18
OncoCyte Announces At Market $3.59 Million Offering of Common Stock and Warrants
4:30pm